Physician profile
Stuart Z Millstone
NPI 1568481224
$3,739.93
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,141 · 2020: $13.08 · 2021: $960 · 2022: $482 · 2023: $124 · 2024: $19.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $895.29 | 2019-2022 | |
| Grifols USA, LLC | $614.33 | 2019-2023 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $484.24 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $453.70 | 2019-2021 | |
| Insmed, INC. | $260.64 | 2019-2024 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $227.78 | 2019 | |
| Genentech USA, INC. | $186.47 | 2019 | |
| Novo Nordisk INC | $124.55 | 2022 | |
| Vapotherm INC | $122.83 | 2019 | |
| Sunovion Pharmaceuticals INC. | $60.62 | 2019 | |
| Mylan Specialty L.P. | $56.38 | 2019 | |
| Genzyme Corporation | $53.26 | 2019 | |
| Jazz Pharmaceuticals INC. | $38.40 | 2019 | |
| Shire North American Group INC | $33.38 | 2019 | |
| Circassia INC. | $31.21 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $30.59 | 2019 | |
| Gilead Sciences, INC. | $29.34 | 2019 | |
| Philips North America LLC | $13.79 | 2019 | |
| Csl Behring | $12.12 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Millstone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.